Breast milk is the gold standard for infant feeding and nutrition. Lysozyme and Human Milk Oligosaccharides (HMOs), which specifically promote the colonization of infant-type HRB, are among the bifidogenic components of breast milk.

Bifidobacterium is one of the first and most prevalent microorganisms to colonize the new-born’s gut. They are among the most crucial factors in developing a healthy gut. The development of the immune, digestive, and metabolic systems, which guard against infection, are just a few of the positive effects of microbiota, which are thought to be crucial for maintaining human health. The secretion of the helper T-cell (Th1) factor increases in new-borns given BB536-enriched baby milk formula. Furthermore, using BB536 supplements promotes the growth of intestinal microbiota dominated by Bifidobacterium.

According to Euromonitor data, the global market for baby food will grow from $ 72.4 billion in 2021 to $ 81.9 billion in 2026 at a CAGR of 3.05%. China and the United States (US) have the world's two (02) largest milk formula markets, with India experiencing one of the fastest growth rates. In 2026, the market for new-born milk formula is expected to reach 189.73 billion yuan, with China accounting for more than half of the global demand. Instead of volume, value, and premiumization are what are fuelling the baby milk formula market's expansion in China. As a result, companies must think about how to capitalize on premiumization and create a distinctive formula that satisfies customer demands.

In order to satisfy consumer demands, manufacturers should consider incorporating probiotics with other beneficial ingredients when developing infant food products in addition to the source, safety, and efficacy of the probiotic strains to produce distinctive formulas that stand out among the competitors.

To ensure compliance with probiotics in your baby food products and for Regulatory assistance in the global market, reach out to a Regulatory expert like Freyr.